Melanie Sena

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

Alcon enters agreement with Google to in-license its "smart lens" Ttechnology for all ocular medical uses.

Pfizer will acquire InnoPharma for $225 million.

GlobalData report reveals the US trails Europe in strengthening its stagnant antibiotics pipeline.

Environmental Monitoring System Improves Efficiency

Sieve Shakers Ensure Reliability

Laboratory Filter-Dryer Enables Scalability

Powderization System Improves Productivity

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

Merck acquires Idenix Pharmaceuticals for $3.85 billion.

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

Eleven new organizations join the global "Fight the Fakes" campaign.

Bayer extends its CEO contract with Marijn Dekkers until 2016.

Teva assigns new executive positions and acquires Labrys Biologics.

Single-Use Mixing System Improves Performance

Centrifuges Increase Capacity and Flexibility

Hybrid Purifer Enhances Efficiency

The CPhI report warns that Turkey's dynamism is being restricted by the current government reimbursement model.

ASCO meeting attendees give artistic interpretations of cancer journeys in the form of public Hope Murals.

The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.

Pfizer and the Avon Foundation for Women Breast Cancer Grants Program will award up to $1 million in grants to advocacy, academic, and other not-for-profit organizations.

The Philippines pharmaceutical market value is expected to increase from approximately $4.3 billion in 2013 to $8 billion by 2020.

GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

PhRMA announces 119 new medicines are in development to treat mental and addictive disorders.

Kymab receives $40 million investment for clinical development of antibody therapeutics.